IMMUNOGLOBULIN DEFICIENCY AND IDIOTYPE EXPRESSION IN CHILDREN DEVELOPING HAEMOPHILUS-INFLUENZAE TYPE-B DISEASE AFTER VACCINATION WITH CONJUGATE VACCINE

被引:25
作者
HOLMES, SJ
LUCAS, AH
OSTERHOLM, MT
FROESCHLE, JE
GRANOFF, DM
机构
[1] WASHINGTON UNIV,SCH MED,ST LOUIS CHILDRENS HOSP,EDWARD MALLINCKRODT DEPT PEDIAT,ST LOUIS,MO 63110
[2] MINNESOTA DEPT HLTH,ACUTE DIS EPIDEMIOL SECT,MINNEAPOLIS,MN
[3] CONNAUGHT LABS INC,SWIFTWATER,PA
[4] CHILDRENS HOSP OAKLAND RES INST,OAKLAND,CA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1991年 / 266卷 / 14期
关键词
D O I
10.1001/jama.266.14.1960
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Haemophilus influenzae type b (Hib) conjugate vaccines are effective in preventing Haemophilus disease in most children. The reasons why the vaccination fails in some children are unknown. This study investigated host factors in children who developed the disease despite conjugate vaccination. Design, Patients, Outcome Measures. A convenience sample of 23 patients in whom Hib disease developed 14 days or more after conjugate vaccination was investigated for the presence of subnormal serum immunoglobulin concentrations and anticapsular antibody responses to Hib disease. We also investigated expression of the Hib idiotype 1 (Hibld-1), a serological marker of a V(K)II chain that comprises a major portion of the normal variable region repertoire of the antibody response to Hib polysaccharide. The results were compared with those of 149 patients in whom the unconjugated Hib polysaccharide vaccine failed and of 90 unvaccinated patients who developed the disease. Results. Compared with children in whom the unconjugated polysaccharide vaccination failed, the relative risk of a subnormal serum concentration of IgM, IgA, IgG, and/or IgG2 in the children in whom the conjugate vaccination failed was 4.9 (95% confidence interval [Cl], 1.8 to 14; P < .003) and of IgG2 was 22 (95% Cl, 3.5 to 146; P < .001). With the exception of the children with subnormal serum immunoglobulin concentrations, most of the children with conjugate vaccination failure showed normal or high anticapsular antibody responses to the disease, whereas the children with polysaccharide vaccination failure showed impaired responses. The Hibld-1 was expressed by the majority of the children in both vaccination failure groups and of the unvaccinated patients. Conclusions. In most patients, vaccination failure is not attributable to lack of expression of the variable region gene encoding Hibld-1. However, children in whom conjugate vaccination has failed frequently have subnormal serum immunoglobulin concentrations and should be evaluated for immunodeficiency.
引用
收藏
页码:1960 / 1965
页数:6
相关论文
共 27 条
  • [1] ADDERSON EE, 1991, J IMMUNOL, V147, P1667
  • [2] EFFICACY OF HEMOPHILUS-INFLUENZAE TYPE-B CAPSULAR POLYSACCHARIDE VACCINE
    BLACK, SB
    SHINEFIELD, HR
    HIATT, RA
    FIREMAN, BH
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1988, 7 (03) : 149 - 156
  • [3] A RANDOMIZED, PROSPECTIVE FIELD TRIAL OF A CONJUGATE VACCINE IN THE PROTECTION OF INFANTS AND YOUNG-CHILDREN AGAINST INVASIVE HAEMOPHILUS-INFLUENZAE TYPE-B DISEASE
    ESKOLA, J
    KAYHTY, H
    TAKALA, AK
    PELTOLA, H
    RONNBERG, PR
    KELA, E
    PEKKANEN, E
    MCVERRY, PH
    MAKELA, PH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (20) : 1381 - 1387
  • [4] IMMUNOGENICITY OF HEMOPHILUS-INFLUENZAE TYPE-B POLYSACCHARIDE OUTER-MEMBRANE PROTEIN CONJUGATE VACCINE IN PATIENTS WHO ACQUIRED HEMOPHILUS DISEASE DESPITE PREVIOUS VACCINATION WITH TYPE B POLYSACCHARIDE VACCINE
    GRANOFF, DM
    CHACKO, A
    LOTTENBACH, KR
    SHEETZ, KE
    [J]. JOURNAL OF PEDIATRICS, 1989, 114 (06) : 925 - 933
  • [5] HAEMOPHILUS-INFLUENZAE TYPE-B DISEASE IN CHILDREN VACCINATED WITH TYPE-B POLYSACCHARIDE VACCINE
    GRANOFF, DM
    SHACKELFORD, PG
    SUAREZ, BK
    NAHM, MH
    CATES, KL
    MURPHY, TV
    KARASIC, R
    OSTERHOLM, MT
    PANDEY, JP
    DAUM, RS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (25) : 1584 - 1590
  • [6] GRANOFF DM, 1988, MONOGR ALLERGY, V23, P256
  • [7] ANTIBODY-RESPONSES TO HAEMOPHILUS-INFLUENZAE TYPE-B POLYSACCHARIDE VACCINE IN RELATION TO KM(1) AND G2M(23) IMMUNOGLOBULIN ALLOTYPES
    GRANOFF, DM
    SHACKELFORD, PG
    PANDEY, JP
    BOIES, EG
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1986, 154 (02) : 257 - 264
  • [8] HOST AND BACTERIAL FACTORS ASSOCIATED WITH HEMOPHILUS-INFLUENZAE TYPE-B DISEASE IN MINNESOTA CHILDREN VACCINATED WITH TYPE-B POLYSACCHARIDE VACCINE
    GRANOFF, DM
    SHEETZ, K
    PANDEY, JP
    NAHM, MH
    RAMBECK, JH
    JACOBS, JL
    MUSSER, J
    SELANDER, RK
    KABEER, M
    MURPHY, TV
    OSTERHOLM, MT
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (05) : 908 - 916
  • [9] IGG SUBCLASS RESPONSE TO IMMUNIZATION WITH HEMOPHILUS-INFLUENZAE TYPE-B POLYSACCHARIDE OUTER MEMBRANE-PROTEIN CONJUGATE VACCINE
    GRANOFF, DM
    WEINBERG, GA
    SHACKELFORD, PG
    [J]. PEDIATRIC RESEARCH, 1988, 24 (02) : 180 - 185
  • [10] PROTECTIVE EFFICACY OF HAEMOPHILUS-INFLUENZAE TYPE-B POLYSACCHARIDE AND CONJUGATE VACCINES IN CHILDREN 18 MONTHS OF AGE AND OLDER
    GREENBERG, DP
    VADHEIM, CM
    BORDENAVE, N
    ZIONTZ, L
    CHRISTENSON, P
    WATERMAN, SH
    WARD, JI
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (08): : 987 - 992